Avalyn Pharma Inc. (AVLN) earnings
Quarterly results of Avalyn Pharma Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 4 quarters, the latest results release and when the next one is expected.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Avalyn Pharma Inc. reported revenue of - and a net loss of $28.9M.
Diluted earnings per share were -$0.98.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$28.9M | -$0.98 |
| Q1 FY2026 | - | - | -$26.9M | -$21.83 |
| Q2 FY2026 | - | - | -$20.2M | -$17.63 |
| Q1 FY2026 | - | - | -$17.5M | -$63.24 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
Get an email when AVLN reports
Follow AVLN and we email you its next results the day they are filed, with the numbers explained.